Profile
| Metric | Value |
|---|---|
| Full Name | Entrada Therapeutics, Inc. |
| Ticker | NASDAQ: TRDA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | entradatx.com |
| Employees | 183 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.05 | |
| Price, 1D Change | -2.24% | |
| $384M | ||
| - | ||
| - | ||
| 1.10 | ||
| $211M | ||
| Revenue, 1Y Change | +63.38% | |
| $1.68 | ||
| EPS, 1Y Change | +931.74% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.68 | ||
| EPS Estimate | -$3.37 | |
| EPS Est. Change | -300.14% | |
| $210.78M | ||
| Revenue Estimate | $32.61M | |
| Revenue Est. Change | -84.53% | |
| Current Price | $10.05 | |
| Price Target | - | $16.50 |
| Price Tgt. Change | - | +64.18% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.09 | -$0.20 | -124.78% | |
| $1.07 | $1.68 | +56.67% | |
| -$3.37 | N/A | -300.14% | |
| -$4.00 | N/A | -337.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $110.87M | $129.01M | +16.36% | |
| $186.51M | $210.78M | +13.01% | |
| $32.61M | N/A | -84.53% | |
| $20.18M | N/A | -90.43% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.05 | |
| $7.57 | ||
| SMA 200 vs Price | -24.68% | |
| $9.16 | ||
| SMA 50 vs Price | -8.82% | |
| 1.10 | ||
| $0.53 | ||
| 48.50 | ||
| 24.02% | ||
| 61.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $210.78M | ||
| $1.68 | ||
| $207.01M | ||
| 98.21% | ||
| $47.01M | ||
| 22.30% | ||
| $65.63M | ||
| 31.13% | ||
| $50.78M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.14 | ||
| 11.15 | ||
| 11.15 | ||
| - | ||
| 2 | ||
| 3.62 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.24 | ||
| 1.13 | ||
| -0.95 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $428.68M | ||
| $101.21M | ||
| $526.32M | ||
| $440.04M | ||
| $97.64M | ||
| $39.48M | ||
| $59.21M | ||
| $7.56M | ||
| $4.26M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $163.77M | ||
| $163.77M | ||
| $3.77M | ||
| $38.47M | ||
| $3.77M | ||
| $0.00 | ||
| $859.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$41.56M | ||
| -$27.80M | ||
| $102.96M | ||
| $3.16M | ||
| -$44.72M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Roth MKM | ||
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with TRDA
Data Sources & References
- TRDA Official Website www.entradatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1689375/000168937525000050/0001689375-25-000050-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1689375/000168937525000011/0001689375-25-000011-index.htm
- TRDA Profile on Yahoo Finance finance.yahoo.com/quote/TRDA
- TRDA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/trda
FAQ
What is the ticker symbol for Entrada Therapeutics, Inc.?
The ticker symbol for Entrada Therapeutics, Inc. is NASDAQ:TRDA
Does Entrada Therapeutics, Inc. pay dividends?
No, Entrada Therapeutics, Inc. does not pay dividends
What sector is Entrada Therapeutics, Inc. in?
Entrada Therapeutics, Inc. is in the Healthcare sector
What industry is Entrada Therapeutics, Inc. in?
Entrada Therapeutics, Inc. is in the Biotechnology industry
What country is Entrada Therapeutics, Inc. based in?
Entrada Therapeutics, Inc. is headquartered in United States
When did Entrada Therapeutics, Inc. go public?
Entrada Therapeutics, Inc. initial public offering (IPO) was on October 29, 2021
Is Entrada Therapeutics, Inc. in the S&P 500?
No, Entrada Therapeutics, Inc. is not included in the S&P 500 index
Is Entrada Therapeutics, Inc. in the NASDAQ 100?
No, Entrada Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Entrada Therapeutics, Inc. in the Dow Jones?
No, Entrada Therapeutics, Inc. is not included in the Dow Jones index
When was Entrada Therapeutics, Inc. last earnings report?
Entrada Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Entrada Therapeutics, Inc. report earnings?
The next expected earnings date for Entrada Therapeutics, Inc. is February 26, 2026